Valneva

Valneva Intangible Assets

The Intangible Assets of Valneva (VLA.PA) as of Oct 19, 2026 is 25.26 M EUR. In the previous year, Intangible Assets was 25.57 M EUR — a change of -1.21% (lower).

Intangible Assets

25.26 MEUR

YoY

-1.21%

Last updated:

Intangible Assets of Valneva is 2024 25.26 M EUR. Intangible Assets of Valneva was 2023 25.57 M EUR. It decreases by -1.21% lower compared to the previous year.

The Valneva Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
48.47 M EUR
Jan 1, 2018
44.89 M EUR
Jan 1, 2019
41.81 M EUR
Jan 1, 2020
35.41 M EUR
Jan 1, 2021
32.70 M EUR
Jan 1, 2022
28.71 M EUR
Jan 1, 2023
25.57 M EUR
Jan 1, 2024
25.26 M EUR
The Valneva Intangible Assets history
YEARIntangible AssetsYoY
25.26 MEUR-1.21%
25.57 MEUR-10.95%
28.71 MEUR-12.20%
32.70 MEUR-7.65%
35.41 MEUR-15.32%
41.81 MEUR-6.86%
44.89 MEUR-7.38%
48.47 MEUR-17.79%
58.96 MEUR-40.18%
98.57 MEUR-6.31%
105.20 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Intangible Assets of Valneva is 25.26 M EUR in 2024.

Intangible Assets of Valneva changed from 25.57 M EUR to 25.26 M EUR, representing a -1.21% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Valneva since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Valneva historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valneva

All Key Metrics — Valneva